Palatin Technologies Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Public

  • Employees
  • 25

Employees

  • Stock Symbol
  • PTN

Stock Symbol

  • Share Price
  • $4.56
  • (As of Friday Closing)

Palatin Technologies General Information

Description

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.

Contact Information

Website
www.palatin.com
Formerly Known As
Interfilm
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 301 Carnegie Center Drive
  • Suite 304
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 301 Carnegie Center Drive
  • Suite 304
  • Princeton, NJ 08540
  • United States
+1 (609)

Palatin Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Palatin Technologies Stock Performance

As of 20-Nov-2026, Palatin Technologies’s stock price is $4.56. Its current market cap is $8.16M with 1.78M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.56 $5.00 $4.51 - $31.00 $8.16M 1.78M 71K -$5.85

Palatin Technologies Financials Summary

As of 30-Sep-2026, Palatin Technologies has a trailing 12-month revenue of $4.7M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 8,529 9,326 4,249 22,159
Revenue 4,699 13,185 0 4,490
EBITDA (18,041) (8,308) (17,033) (29,380)
Net Income (18,113) (8,378) (17,307) (29,736)
Total Assets 4,718 8,524 3,267 10,742
Total Debt 160 224 164 590
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Palatin Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Palatin Technologies‘s full profile, request access.

Request a free trial

Palatin Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modu
Pharmaceuticals
Princeton, NJ
25 As of 2026

Ocala, FL
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Palatin Technologies Competitors (17)

One of Palatin Technologies’s 17 competitors is AIM ImmunoTech, a Corporation company based in Ocala, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AIM ImmunoTech Corporation Ocala, FL
Aldeyra Therapeutics Formerly VC-backed Lexington, MA
Kala Bio Formerly VC-backed Arlington, MA
Ardelyx Formerly VC-backed Waltham, MA
Paratek Pharmaceuticals Private Equity-Backed King of Prussia, PA
You’re viewing 5 of 17 competitors. Get the full list »

Palatin Technologies Patents

Palatin Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3166466-A1 Diamine-linked receptor-specific cyclic peptides Pending 03-Feb-2020
WO-2021158463-A1 Diamine-linked receptor-specific cyclic peptides Inactive 03-Feb-2020
AU-2021217939-A1 Reverse amide-linked melanocortin receptor-specific cyclic peptides Pending 03-Feb-2020
CA-3166448-A1 Reverse amide-linked melanocortin receptor-specific cyclic peptides Pending 03-Feb-2020
EP-4100042-A1 Reverse amide-linked melanocortin receptor-specific cyclic peptides Pending 03-Feb-2020 C07K7/64
To view Palatin Technologies’s complete patent history, request access »

Palatin Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Palatin Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Palatin Technologies‘s full profile, request access.

Request a free trial

Palatin Technologies ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Palatin Technologies’s complete esg history, request access »

Palatin Technologies FAQs

  • When was Palatin Technologies founded?

    Palatin Technologies was founded in 1986.

  • Where is Palatin Technologies headquartered?

    Palatin Technologies is headquartered in Princeton, NJ.

  • What is the size of Palatin Technologies?

    Palatin Technologies has 25 total employees.

  • What industry is Palatin Technologies in?

    Palatin Technologies’s primary industry is Pharmaceuticals.

  • Is Palatin Technologies a private or public company?

    Palatin Technologies is a Public company.

  • What is Palatin Technologies’s stock symbol?

    The ticker symbol for Palatin Technologies is PTN.

  • What is the current stock price of Palatin Technologies?

    As of 20-Nov-2026 the stock price of Palatin Technologies is $4.56.

  • What is the current market cap of Palatin Technologies?

    The current market capitalization of Palatin Technologies is $8.16M.

  • What is Palatin Technologies’s current revenue?

    The trailing twelve month revenue for Palatin Technologies is $4.7M.

  • Who are Palatin Technologies’s competitors?

    AIM ImmunoTech, Aldeyra Therapeutics, Kala Bio, Ardelyx, and Paratek Pharmaceuticals are some of the 17 competitors of Palatin Technologies.

  • What is Palatin Technologies’s annual earnings per share (EPS)?

    Palatin Technologies’s EPS for 12 months was -$5.85.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process